Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review | BMC Medicine
Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11.
Google Scholar
Yuan Q, Zhang H, Xie Y, Lin W, Peng L, Wang L, et al. Development of prognostic model for patients at CKD stage 3a and 3b in South Central China using computational intelligence. Clin Exp Nephrol. 2020;24(10):865–75.
Google Scholar
Zhou F, Gillespie A, Gligorijevic D, Gligorijevic J, Obradovic Z. Use of disease embedding technique to predict the risk of progression to end-stage renal disease. J Biomed Inform. 2020;105:N.PAG-N.PAG.
Sullivan MK, Carrero J-J, Jani BD, Anderson C, McConnachie A, Hanlon P, et al. The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. BMC Med. 2022;20(1):420.
Google Scholar
MacRae C, Mercer SW, Guthrie B, Henderson D. Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care. Br J Gen Pract. 2021;71(704):e243–9.
Google Scholar
Ho ISS, Azcoaga-Lorenzo A, Akbari A, Davies J, Khunti K, Kadam UT, et al. Measuring multimorbidity in research: Delphi consensus study. BMJ Med. 2022;1(1):e000247.
Google Scholar
Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142–51.
Google Scholar
Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018;3(7):e323–32.
Google Scholar
Dalrymple LS, Katz R, Rifkin DE, Siscovick D, Newman AB, Fried LF, et al. Kidney function and prevalent and incident frailty. Clin J Am Soc Nephrol. 2013;8(12):2091–9.
Google Scholar
Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, et al. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis. 2012;60(6):912–21.
Google Scholar
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.
Google Scholar
Chowdhury R, Peel NM, Krosch M, Hubbard RE. Frailty and chronic kidney disease: a systematic review. Arch Gerontol Geriatr. 2017;68:135–42.
Google Scholar
Vetrano DL, Palmer K, Marengoni A, Marzetti E, Lattanzio F, Roller-Wirnsberger R, et al. Frailty and multimorbidity: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. 2019;74(5):659–66.
Google Scholar
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Google Scholar
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.
Google Scholar
Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722–7.
Google Scholar
Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8(1):24.
Google Scholar
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–57.
Google Scholar
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.
Google Scholar
Sullivan MK, Rankin AJ, Jani BD, Mair FS, Mark PB. Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. BMJ Open. 2020;10(6):e038401.
Google Scholar
Sullivan MK, Jani BD, McConnachie A, Hanlon P, McLoone P, Nicholl BI, et al. Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings. BMC Med. 2021;19(1):278.
Google Scholar
Sullivan MK, Jani BD, Lees JS, Welsh CE, McConnachie A, Stanley B, et al. Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clin Kidney J. 2021;14(11):2409–19.
Google Scholar
Ramspek CL, de Jong Y, Dekker FW, van Diepen M. Towards the best kidney failure prediction tool: a systematic review and selection aid. Nephrol Dial Transplant. 2020;35(9):1527–38.
Google Scholar
National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management (NICE guideline NG203). 2021. https://www.nice.org.uk/guidance/ng203.
Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553–9.
Google Scholar
Debray TPA, Damen JAAG, Snell KIE, Ensor J, Hooft L, Reitsma JB, et al. A guide to systematic review and meta-analysis of prediction model performance. BMJ. 2017;356:i6460.
Google Scholar
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
Google Scholar
Moons KG, de Groot JA, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.
Google Scholar
Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170(1):W1-w33.
Google Scholar
Al-Wahsh H, Tangri N, Quinn R, Liu P, Ferguson Ms T, Fiocco M, et al. Accounting for the competing risk of death to predict kidney failure in adults with stage 4 chronic kidney disease. JAMA Netw Open. 2021;4(5):e219225.
Google Scholar
Ali I, Donne RL, Kalra PA. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility. BMC Nephrol. 2021;22(1):194.
Google Scholar
Bai Q, Su C, Tang W, Li Y. Machine learning to predict end stage kidney disease in chronic kidney disease. Sci Rep. 2022;12(1):8377.
Google Scholar
Bai X, Guo Q, Lou Y, Nie P, Zhu Y, Li B, et al. Validation of the renal risk score for antineutrophil cytoplasmic antibody-associated glomerulonephritis in a Chinese population. Clin Rheumatol. 2021;40(12):5009–17.
Google Scholar
Barbour SJ, Coppo R, Zhang H, Liu Z-H, Suzuki Y, Matsuzaki K, et al. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy. Kidney Int. 2022;102(1):160–72.
Google Scholar
Barbour SJ, Coppo R, Zhang H, Liu Z-H, Suzuki Y, Matsuzaki K, et al. Evaluating a new International Risk-Prediction Tool in IgA nephropathy. JAMA Intern Med. 2019;179(7):942–52.
Google Scholar
Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts ISD, Feehally J, et al. The MEST score provides earlier risk prediction in lgA nephropathy. Kidney Int. 2016;89(1):167–75.
Google Scholar
Bellocchio F, Lonati C, Ion Titapiccolo J, Nadal J, Meiselbach H, Schmid M, et al. Validation of a Novel predictive algorithm for kidney failure in patients suffering from chronic kidney disease: The Prognostic Reasoning System for Chronic Kidney Disease (PROGRES-CKD). Int J Environ Res Public Health. 2021;18(23):12649.
Google Scholar
Belur Nagaraj S, Pena MJ, Ju W, Heerspink HL. Machine-learning-based early prediction of end-stage renal disease in patients with diabetic kidney disease using clinical trials data. Diabetes Obes Metab. 2020;22(12):2479–86.
Google Scholar
Bon G, Jullien P, Masson I, Sauron C, Dinic M, Claisse G, et al. Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis. Nephrol Dial Transplant. 2023;38(10):2257–65.
Google Scholar
Bundy JD, Mills KT, Anderson AH, Yang W, Chen J, He J. Prediction of end-stage kidney disease using estimated glomerular filtration rate with and without race : a prospective cohort study. Ann Intern Med. 2022;175(3):305–13.
Google Scholar
Chen T, Li X, Li Y, Xia E, Qin Y, Liang S, et al. Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am J Kidney Dis. 2019;74(3):300–9.
Google Scholar
Cheng Y, Shang J, Liu D, Xiao J, Zhao Z. Development and validation of a predictive model for the progression of diabetic kidney disease to kidney failure. Ren Fail. 2020;42(1):550–9.
Google Scholar
Chu CD, McCulloch CE, Hsu RK, Powe NR, Bieber B, Robinson BM, et al. Utility of the kidney failure risk equation and estimated GFR for estimating time to kidney failure in advanced CKD. Am J Kidney Dis. 2023;82:386–394.e1.
Google Scholar
da Silva BM, Charreu J, Duarte I, Outerelo C, Gameiro J. Validation of the kidney failure risk equation in a Portuguese cohort. Nefrologia (Engl Ed). 2023;43(4):467–73.
da Silva BM, Dores M, Silva O, Pereira M, Outerelo C, Fortes A, et al. Planning vascular access creation: the promising role of the kidney failure risk equation. J Vasc Access. 2023;0(0).
Dai D, Alvarez PJ, Woods SD. A predictive model for progression of chronic kidney disease to kidney failure using a large administrative claims database. Clinicoecon Outcomes Res. 2021;13:475–86.
Google Scholar
Desai AS, Toto R, Jarolim P, Uno H, Eckardt K-U, Kewalramani R, et al. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis. 2011;58(5):717–28.
Google Scholar
Dimitrov BD, Ruggenenti P, Stefanov R, Perna A, Remuzzi G. Chronic nephropathies: individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model. Nephron Clin Pract. 2003;95(2):c47–59.
Google Scholar
Edmonston D, Wojdyla D, Mehta R, Cai X, Lora C, Cohen D, et al. Single measurements of carboxy-terminal fibroblast growth factor 23 and clinical risk prediction of adverse outcomes in CKD. Am J Kidney Dis. 2019;74(6):771–81.
Google Scholar
Fenton A, Jesky MD, Webster R, Stringer SJ, Yadav P, Chapple I, et al. Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease. PLoS One. 2018;13(5):e0197043.
Google Scholar
Floyd L, Bate S, Hadi Kafagi A, Brown N, Scott J, Srikantharajah M, et al. Risk stratification to predict renal survival in anti-glomerular basement membrane disease. J Am Soc Nephrol. 2023;34(3):505–14.
Google Scholar
Forsblom C, Moran J, Harjutsalo V, Loughman T, Wadén J, Tolonen N, et al. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes. Diabetes Care. 2014;37(8):2334–42.
Google Scholar
Gibertoni D, Rucci P, Mandreoli M, Corradini M, Martelli D, Russo G, et al. Temporal validation of the CT-PIRP prognostic model for mortality and renal replacement therapy initiation in chronic kidney disease patients. BMC Nephrol. 2019;20(1):177.
Google Scholar
Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, et al. The kidney failure risk equation: evaluation of novel input variables including eGFR estimated using the CKD-EPI 2021 equation in 59 cohorts. J Am Soc Nephrol. 2023;34(3):482–94.
Google Scholar
Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, et al. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93(6):1442–51.
Google Scholar
Haaskjold YL, Lura NG, Bjørneklett R, Bostad L, Bostad LS, Knoop T. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up. Nephrol Dial Transplant. 2023;38(5):1183–91.
Google Scholar
Hallan SI, Rifkin DE, Potok OA, Katz R, Langlo KA, Bansal N, et al. Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate. Kidney Int. 2019;96(3):728–37.
Google Scholar
Hasegawa T, Sakamaki K, Koiwa F, Akizawa T, Hishida A. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol. 2019;23(2):189–98.
Google Scholar
Hoshino J, Mise K, Ueno T, Imafuku A, Kawada M, Sumida K, et al. A pathological scoring system to predict renal outcome in diabetic nephropathy. Am J Nephrol. 2015;41(4–5):337–44.
Google Scholar
Hsu CY, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, et al. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int. 2017;91(1):196–203.
Google Scholar
Hundemer GL, Tangri N, Sood MM, Ramsay T, Bugeja A, Brown PA, et al. Performance of the kidney failure risk equation by disease etiology in advanced CKD. Clin J Am Soc Nephrol. 2020;15(10):1424–32.
Google Scholar
Hwang D, Choi K, Cho N-J, Park S, Yu BC, Gil H-W, et al. Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy. Nephrology. 2021;26(7):594–602.
Google Scholar
Ingwiller M, Krummel T, Dimitrov Y, Muller C, Ott J, Chantrel F, et al. Evaluation of a predictive model of end-stage kidney disease in a French-based cohort. Int Urol Nephrol. 2022;54(9):2335–42.
Google Scholar
Irish GL, Cuthbertson L, Kitsos A, Saunder T, Clayton PA, Jose MD. The kidney failure risk equation predicts kidney failure: validation in an Australian cohort. Nephrology. 2023;28(6):328–35.
Google Scholar
Jahan S, Hale J, Malacova E, Hurst C, Kark A, Mallett A. Real world evaluation of kidney failure risk equations in predicting progression from chronic kidney disease to kidney failure in an Australian cohort. J Nephrol. 2024;37(1):231–7.
Jiang S, Yu T, Zhang Z, Fang J, Wang Y, Yang Y, et al. Prognostic nomogram and score to predict renal survival of patients with biopsy-proven diabetic nephropathy. Diabetes Res Clin Pract. 2019;155:107809.
Google Scholar
Johnson ES, Thorp ML, Platt RW, Smith DH. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis. 2008;52(4):653–60.
Google Scholar
Johnson ES, Thorp ML, Yang X, Charansonney OL, Smith DH. Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis. 2007;50(4):559–65.
Google Scholar
Kang MW, Tangri N, Kim YC, An JN, Lee J, Li L, et al. An independent validation of the kidney failure risk equation in an Asian population. Sci Rep. 2020;10(1):12920.
Google Scholar
Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, et al. Addition of eGFR and age improves the prognostic absolute renal risk-model in 1,134 Norwegian patients with IgA nephropathy. Am J Nephrol. 2015;41(3):210–9.
Google Scholar
Kong W, Ni A, Wang M, Huang X, Chen L, Ma Y, et al. The predictive value of Berden’s classification versus renal risk score for renal survival of Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Clin Exp Rheumatol. 2023;41(4):893–901.
Google Scholar
Kwan B, Fuhrer T, Zhang J, Darshi M, Van Espen B, Montemayor D, et al. Metabolomic markers of kidney function decline in patients with diabetes: evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020;76(4):511–20.
Google Scholar
Kwek JL, Pang HQJ, Li H, Lim WWL, Choo JCJ, Choong HL, et al. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort. Singapore Med J. 2022;63(6):313–8.
Google Scholar
Landray MJ, Emberson JR, Blackwell L, Dasgupta T, Zakeri R, Morgan MD, et al. Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis. 2010;56(6):1082–94.
Google Scholar
Lee M-J, Park J-H, Moon YR, Jo S-Y, Yoon D, Park RW, et al. Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data? PLoS One. 2018;13(10):e0204586.
Google Scholar
Lennartz CS, Pickering JW, Seiler-Mußler S, Bauer L, Untersteller K, Emrich IE, et al. External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters. Clin J Am Soc Nephrol. 2016;11(4):609–15.
Google Scholar
Lim CC, Chee ML, Cheng C-Y, Kwek JL, Foo M, Wong TY, et al. Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease. PLoS One. 2019;14(2):e0212590.
Google Scholar
Lin Y, Shao H, Fonseca V, Anderson AH, Batuman V, Shi L. A prediction model on incident ESKD among individuals with T2D and CKD. J Diabetes Complications. 2023;37(4):108450.
Google Scholar
Maher F, Teece L, Major RW, Bradbury N, Medcalf JF, Brunskill NJ, et al. Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study. Diagn Progn Res. 2023;7(1):22.
Google Scholar
Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 2019;16(11):e1002955.
Google Scholar
Massy ZA, Lambert O, Metzger M, Sedki M, Chaubet A, Breuil B, et al. Machine learning-based urine peptidome analysis to predict and understand mechanisms of progression to kidney failure. Kidney Int Rep. 2023;8(3):544–55.
Google Scholar
Maziarz M, Black RA, Fong CT, Himmelfarb J, Chertow GM, Hall YN. Evaluating risk of ESRD in the urban poor. J Am Soc Nephrol. 2015;26(6):1434–42.
Google Scholar
Maziarz M, Chertow GM, Himmelfarb J, Hall YN. Homelessness and risk of end-stage renal disease. J Health Care Poor Underserved. 2014;25(3):1231–44.
Google Scholar
Naranjo FS, Sang Y, Ballew SH, Stempniewicz N, Dunning SC, Levey AS, et al. Estimating Kidney Failure Risk Using Electronic Medical Records. Kidney360. 2021;2(3):415–24.
Google Scholar
Orlandi PF, Fujii N, Roy J, Chen H-Y, Lee Hamm L, Sondheimer JH, et al. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol. 2018:N.PAG-N.PAG.
Ouyang Y, Zhao Z, Li G, Luo H, Xu F, Shao L, et al. A validation study comparing risk prediction models of IgA nephropathy. Front Immunol. 2021;12:753901.
Google Scholar
Park KS, Han SH, Kie JH, Nam KH, Lee MJ, Lim BJ, et al. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy. Hum Pathol. 2014;45(2):236–43.
Google Scholar
Peeters MJ, van Zuilen AD, van den Brand JAJG, Bots ML, Blankestijn PJ, Wetzels JFM. Validation of the kidney failure risk equation in European CKD patients. Nephrol Dial Transplant. 2013;28(7):1773–9.
Google Scholar
Pesce F, Diciolla M, Binetti G, Naso D, Ostuni VC, Di Noia T, et al. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients. Nephrol Dial Transplant. 2016;31(1):80–6.
Google Scholar
Prouvot J, Pambrun E, Couchoud C, Vigneau C, Roche S, Allot V, et al. Low performance of prognostic tools for predicting dialysis in elderly people with advanced CKD. J Nephrol. 2021;34(4):1201–13.
Google Scholar
Ramspek CL, Evans M, Wanner C, Drechsler C, Chesnaye NC, Szymczak M, et al. Kidney failure prediction models: a comprehensive external validation study in patients with advanced CKD. J Am Soc Nephrol. 2021;32(5):1174–86.
Google Scholar
Sato R, Joh K, Komatsuda A, Ohtani H, Okuyama S, Togashi M, et al. Validation of the Japanese histologic classification 2013 of immunoglobulin A nephropathy for prediction of long-term prognosis in a Japanese single-center cohort. Clin Exp Nephrol. 2015;19(3):411–8.
Google Scholar
Schena FP, Anelli VW, Trotta J, Di Noia T, Manno C, Tripepi G, et al. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy. Kidney Int. 2021;99(5):1179–88.
Google Scholar
Schroeder EB, Yang X, Thorp ML, Arnold BM, Tabano DC, Petrik AF, et al. Predicting 5-year risk of RRT in stage 3 or 4 cKD: development and external validation. Clin J Am Soc Nephrol. 2017;12(1):87–94.
Google Scholar
Sheer R, Nair R, Pasquale MK, Evers T, Cockrell M, Gay A, et al. Predictive risk models to identify patients at high-risk for severe clinical outcomes with chronic kidney disease and type 2 diabetes. J Prim Care Community Health. 2022;13:21501319211063730.
Google Scholar
Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, et al. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD). Nephrol Dial Transplant. 2013;28(6):1569–79.
Google Scholar
Stefan G, Stancu S, Zugravu A, Petre N, Mandache E, Mircescu G. Towards a simplified renal histopathological prognostic score in glomerular nephropathies. Histopathology. 2020;77(6):926–35.
Google Scholar
Sud M, Tangri N, Levin A, Pintilie M, Levey AS, Naimark DM. CKD stage at nephrology referral and factors influencing the risks of ESRD and death. Am J Kidney Dis. 2014;63(6):928–36.
Google Scholar
Sun L, Shang J, Xiao J, Zhao Z. Development and validation of a predictive model for end-stage renal disease risk in patients with diabetic nephropathy confirmed by renal biopsy. PeerJ. 2020;8:e8499.
Google Scholar
Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315(2):164–74.
Google Scholar
Tangri N, Inker LA, Hiebert B, Wong J, Naimark D, Kent D, et al. A dynamic predictive model for progression of CKD. Am J Kidney Dis. 2017;69(4):514–20.
Google Scholar
Thanabalasingam SJ, Iliescu EA, Norman PA, Day AG, Akbari A, Hundemer GL, et al. Independent external validation and comparison of death and kidney replacement therapy prediction models in advanced CKD. Kidney Med. 2022;4(4):100440.
Google Scholar
van den Brand JAJG, Dijkstra TMH, Wetzels J, Stengel B, Metzger M, Blankestijn PJ, et al. Predicting kidney failure from longitudinal kidney function trajectory: a comparison of models. PLoS One. 2019;14(5):e0216559.
Google Scholar
Wang H, Zheng C, Lu Y, Jiang Q, Yin R, Zhu P, et al. Urinary fibrinogen as a predictor of progression of CKD. Clin J Am Soc Nephrol. 2017;12(12):1922–9.
Google Scholar
Wang R-X, Wang J-W, Li Z-Y, Chen S-F, Yu X-J, Wang S-X, et al. A modified renal risk score for Chinese patients with antineutrophil cytoplasmic antibody-associated vasculitis. BMC Med. 2023;21(1):45.
Google Scholar
Wang Y, Nguyen FNHL, Allen JC, Lew JQL, Tan NC, Jafar TH. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. BMC Nephrol. 2019;20(1):451.
Google Scholar
Whitlock RH, Chartier M, Komenda P, Hingwala J, Rigatto C, Walld R, et al. Validation of the Kidney Failure Risk Equation in Manitoba. Can J Kidney Health Dis. 2017;4:2054358117705372.
Google Scholar
Wu L, Wang G, Yang B, Liu X, Xie C, Feng X, et al. Urinary matrix metalloproteinase 7 activated by oxidative stress predicts kidney prognosis in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis. Antioxid Redox Signal. 2022;37(4):246–56.
Google Scholar
Xie J, Kiryluk K, Wang W, Wang Z, Guo S, Shen P, et al. Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS One. 2012;7(6):e38904.
Google Scholar
Xie Y, Maziarz M, Tuot DS, Chertow GM, Himmelfarb J, Hall YN. Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study. BMC Nephrol. 2016;17(1):57.
Google Scholar
Xu Q, Wang Y, Fang Y, Feng S, Chen C, Jiang Y. An easy-to-operate web-based calculator for predicting the progression of chronic kidney disease. J Transl Med. 2021;19(1):288.
Google Scholar
Yamanouchi M, Hoshino J, Ubara Y, Takaichi K, Kinowaki K, Fujii T, et al. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy. PLoS One. 2018;13(1):e0190930.
Google Scholar
Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, et al. Urinary matrix metalloproteinase 7 and prediction of IgA nephropathy progression. Am J Kidney Dis. 2020;75(3):384–93.
Google Scholar
Ye W, Ding X, Putnam N, Farej R, Singh R, Wang D, et al. Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors. J Diabetes Complications. 2022;36(5):108180.
Google Scholar
Zacharias HU, Altenbuchinger M, Schultheiss UT, Raffler J, Kotsis F, Ghasemi S, et al. A predictive model for progression of CKD to kidney failure based on routine laboratory tests. Am J Kidney Dis. 2022;79(2):217.
Google Scholar
Zacharias HU, Altenbuchinger M, Schultheiss UT, Samol C, Kotsis F, Poguntke I, et al. A novel metabolic signature to predict the requirement of dialysis or renal transplantation in patients with chronic kidney disease. J Proteome Res. 2019;18(4):1796–805.
Google Scholar
Zhang J, Huang B, Liu Z, Wang X, Xie M, Guo R, et al. External validation of the International IgA Nephropathy Prediction Tool. Clin J Am Soc Nephrol. 2020;15(8):1112–20.
Google Scholar
Zhang J, Song H, Li D, Lv Y, Chen B, Zhou Y, et al. Role of clinicopathological features for the early prediction of prognosis in lupus nephritis. Immunol Res. 2021;69(3):285–94.
Google Scholar
Zhang M, Lei N, Zhang X-L, Xu Y, Chen H-F, Fu L-Z, et al. Developing and validating a prognostic prediction model for patients with chronic kidney disease stages 3–5 based on disease conditions and intervention methods: a retrospective cohort study in China. BMJ Open. 2022;12(5):e054989.
Google Scholar
Zhang X, Luo F, Chen R, Shen J, Liu X, Shi Y, et al. Use of histologic parameters to predict glomerular disease progression: findings from the China Kidney Biopsy Cohort Study. Am J Kidney Dis. 2023;81(4):416–24.e1.
Google Scholar
Zhang Y, Jiang Q, Xie J, Qi C, Li S, Wang Y, et al. Modified arteriosclerosis score predicts the outcomes of diabetic kidney disease. BMC Nephrol. 2021;22(1):1–14.
Google Scholar
Zhu Y, Huang X, Li L. Dynamic prediction of time to a clinical event with sparse and irregularly measured longitudinal biomarkers. Biom J. 2020;62(6):1371–93.
Google Scholar
Zhu Y, Xu W, Wan C, Chen Y, Zhang C. Prediction model for the risk of ESKD in patients with primary FSGS. Int Urol Nephrol. 2022;54(12):3211–9.
Google Scholar
Zou Y, Zhao L, Zhang J, Wang Y, Wu Y, Ren H, et al. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease. Ren Fail. 2022;44(1):562–70.
Google Scholar
Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011;22(4):752–61.
Google Scholar
Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, et al. Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int. 2018;94(6):1177–88.
Google Scholar
Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–45.
Google Scholar
Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009;24(10):3068–74.
Google Scholar
Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29(6):829–42.
Google Scholar
Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, et al. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. J Nephrol. 2013;26(2):350–7.
Google Scholar
Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld J-P, et al. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL Study. Clin J Am Soc Nephrol. 2006;1(4):761–7.
Google Scholar
Marks A, Fluck N, Prescott GJ, Robertson L, Simpson WG, Cairns Smith W, et al. Looking to the future: predicting renal replacement outcomes in a large community cohort with chronic kidney disease. Nephrol Dial Transplant. 2015;30(9):1507–17.
Google Scholar
Sethi S, D’Agati VD, Nast CC, Fogo AB, De Vriese AS, Markowitz GS, et al. A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int. 2017;91(4):787–9.
Google Scholar
Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H, et al. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol. 2013;8(12):2082–90.
Google Scholar
Livingstone SJ, Guthrie B, Donnan PT, Thompson A, Morales DR. Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. BMC Med. 2022;20(1):152.
Google Scholar
Livingstone SJ, Morales DR, McMinn M, Eke C, Donnan P, Guthrie B. Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population. BMJ Med. 2022;1(1):e000316.
Google Scholar
Milders J, Ramspek CL, Janse RJ, Bos WJW, Rotmans JI, Dekker FW, van Diepen M. Prognostic Models in Nephrology: Where Do We Stand and Where Do We Go from Here? Mapping Out the Evidence in a Scoping Review. J Am Soc Nephrol. 2024;35(3):367–80.
de Jong Y, Ramspek CL, Zoccali C, Jager KJ, Dekker FW, van Diepen M. Appraising prediction research: a guide and meta-review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Nephrology. 2021;26(12):939–47.
Google Scholar
link
